FindMyRecallSubscribe
Class I: serious health riskTerminated

AuroMedics Pharma Ampicillin and Sulbactam for Injection Recall

Ampicillin and Sulbactam for Injection, USP, 3 gram*s/vial, For Intramuscular or Intrav…

AuroMedics Pharma LLC · East Windsor, NJ

Risk level
Class I
Reported by FDA
May 16, 2018
Recall ID
D-0866-2018
Check your lot numberHow we source this data

Summary

AuroMedics Pharma recalled Ampicillin and Sulbactam for Injection starting May 1, 2018. The FDA classified it as Class I (serious health risk) and published enforcement report D-0866-2018 on May 16, 2018. Reason: Presence of Particulate Matter: confirmed customer report of the presence of visible particulate matter believed to be red rubber particles from the manufacturing process of the active ingredients. Status: Terminated.

Why it was recalled

Presence of Particulate Matter: confirmed customer report of the presence of visible particulate matter believed to be red rubber particles from the manufacturing process of the active ingredients.

Product description

Ampicillin and Sulbactam for Injection, USP, 3 gram*s/vial, For Intramuscular or Intravenous Use, Sterile, Manufactured for: AuroMedics Pharma LLC, 6 Wheeling Road, Dayton, NJ, NDC 55150-117-20.

Lot numbers, UPCs & expiration codes

Lot #: AS0317041-A, AS0317035-A; Exp August 2019

Where it was sold

Nationwide in the USA and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0866-2018
Classification
Class I
Status
Terminated
Recall initiated
May 1, 2018
FDA report date
May 16, 2018
Quantity
54,720 vials
Recall type
Voluntary: Firm initiated
Recalling firm
AuroMedics Pharma LLC

Original FDA data

Every field from FDA enforcement report D-0866-2018, exactly as published.

Show all FDA fields
City
East Windsor
State
NJ
Status
Terminated
Country
United States
Event ID
79996
Address
279 Princeton Hightstown Rd
Code information
Lot #: AS0317041-A, AS0317035-A; Exp August 2019
Postal code
08520-1401
Report date
May 16, 2018
Product type
Drugs
Recall number
D-0866-2018
Classification
Class I
Recalling firm
AuroMedics Pharma LLC
Product quantity
54,720 vials
Termination date
Nov 6, 2024
Reason for recall
Presence of Particulate Matter: confirmed customer report of the presence of visible particulate matter believed to be red rubber particles from the manufacturing process of the active ingredients.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Ampicillin and Sulbactam for Injection, USP, 3 gram*s/vial, For Intramuscular or Intravenous Use, Sterile, Manufactured for: AuroMedics Pharma LLC, 6 Wheeling Road, Dayton, NJ, NDC 55150-117-20.
Distribution pattern
Nationwide in the USA and Puerto Rico
Recall initiation date
May 1, 2018
Initial firm notification
Letter
Center classification date
Jun 14, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0866-2018, published May 16, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls